Nifty

:

24870.10

Sensex

:

81306.85

-213.65 (-0.85%)
-693.86 (-0.85%)

Login

Nifty
Sensex

:
:

24870.10
81306.85

-213.65 (-0.85%)
-693.86 (-0.85%)

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

48/99

BSE: 506690 | NSE: UNICHEMLAB

Watchlist

NSE BSE

502.80

22-Aug-2025

Open
High
Low
Previous Close

500
511
500
503.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

9588
4837205.7
937.95
483

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,546.69
27.11
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,859.03
N/A
1.46

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.71
11.31
16.27

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.92
23.79
-

PAT CAGR (%)

10 Years
5 Years
3 Years

2.40
31.73
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

1.30
1.18
1.46

EV:EBITDA (Average)

8 Years
5 Years
3 Years

24.37
22.48
21.23

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS -10.01 19.53
P/E Ratio -50.23 25.75
Revenue 1657 2111
EBITDA 100 265
Net Income -70 138
ROA -2.2 4.1
P/B Ratio 1.54 1.44
ROE -2.94 5.71
FCFF -28 -162
FCFF Yield -0.6 -3.51
Net Debt 107 342
BVPS 325.91 348.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 384.25 389.75 -1.41% 461.24 399.24 15.53% 447.83 362.43 23.56% 436.88 333.83 30.87%
Expenses 358.51 349.56 2.56% 386.26 368.65 4.78% 373.62 343.11 8.89% 372.38 341.14 9.16%
EBITDA 25.74 40.19 -35.95% 74.98 30.59 145.11% 74.21 19.32 284.11% 64.50 -7.31 -
EBIDTM 6.70% 10.31% 16.26% 7.66% 16.57% 5.33% 14.76% -2.19%
Other Income 4.25 8.77 -51.54% 6.05 7.04 -14.06% 18.93 9.94 90.44% 7.08 7.58 -6.60%
Interest 1.93 1.38 39.86% 1.53 1.76 -13.07% 2.89 2.36 22.46% 1.82 3.82 -52.36%
Depreciation 29.93 26.10 14.67% 27.47 25.22 8.92% 28.45 25.61 11.09% 26.39 27.26 -3.19%
PBT -1.87 21.48 - 56.03 -114.97 - 61.80 69.30 -10.82% 43.37 -30.81 -
Tax -0.02 0.00 - 4.81 0.00 0 14.91 0.00 0 0.00 0.00 0
PAT -1.85 21.48 - 51.22 -114.97 - 46.89 69.30 -32.34% 43.37 -30.81 -
PATM -0.48% 5.51% 11.10% -28.80% 10.47% 19.12% 9.93% -9.23%
EPS -0.26 3.05 - 7.28 -16.33 - 6.66 9.84 -32.32% 6.16 -4.38 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 526.60 483.34 8.95% 587.18 459.60 27.76% 533.09 465.72 14.47% 462.16 415.63 11.20%
Expenses 504.11 443.19 13.75% 503.48 437.97 14.96% 447.57 434.60 2.98% 404.63 406.86 -0.55%
EBITDA 22.49 40.15 -43.99% 83.70 21.63 286.96% 85.52 31.12 174.81% 57.53 8.77 555.99%
EBIDTM 4.27% 8.31% 14.25% 4.71% 16.04% 6.68% 12.45% 2.11%
Other Income 6.82 3.76 81.38% 9.25 6.15 50.41% 13.62 11.27 20.85% 8.79 5.53 58.95%
Interest 6.54 4.03 62.28% 5.46 4.59 18.95% 6.75 5.58 20.97% 4.79 6.73 -28.83%
Depreciation 31.79 32.07 -0.87% 29.69 30.88 -3.85% 30.54 31.62 -3.42% 28.54 29.45 -3.09%
PBT -9.02 7.81 - 57.80 -133.31 - 61.85 73.20 -15.51% 32.99 -21.88 -
Tax 1.45 5.74 -74.74% 4.83 3.43 40.82% 4.00 -0.02 - 2.50 2.61 -4.21%
PAT -10.47 2.07 - 52.97 -136.74 - 57.85 73.22 -20.99% 30.49 -24.49 -
PATM -1.99% 0.43% 9.02% -29.75% 10.85% 15.72% 6.60% -5.89%
EPS -1.49 0.29 - 7.52 -19.42 - 8.22 10.40 -20.96% 4.33 -3.48 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,730.20 1,735.70 1,442.16 1,072.43 942.93 1,123.97 904.44 975.88 1,231.38 1,418.41 1,220.52 Net Sales Growth 16.49% 20.35% 34.48% 13.73% -16.11% 24.27% -7.32% -20.75% -13.19% 16.21% Cost Of Goods Sold 804.25 685.34 592.47 455.40 324.56 359.33 311.23 339.36 274.57 188.07 395.62 Gross Profit 925.95 1,050.36 849.69 617.03 618.37 764.64 593.21 636.52 956.81 1,230.34 824.90 GP Margin 53.52% 60.52% 58.92% 57.54% 65.58% 68.03% 65.59% 65.23% 77.70% 86.74% 67.59% Total Expenditure 1,490.77 1,481.82 1,391.25 1,165.35 986.48 1,028.51 995.05 1,034.20 1,214.03 1,252.60 1,078.24 Power & Fuel Cost - 106.63 105.64 101.41 77.12 67.95 72.14 75.43 48.26 40.76 37.34 % Of Sales - 6.14% 7.33% 9.46% 8.18% 6.05% 7.98% 7.73% 3.92% 2.87% 3.06% Employee Cost - 287.51 283.15 270.86 250.79 234.04 205.16 176.76 146.54 117.68 209.60 % Of Sales - 16.56% 19.63% 25.26% 26.60% 20.82% 22.68% 18.11% 11.90% 8.30% 17.17% Manufacturing Exp. - 238.45 222.94 189.07 189.10 207.65 139.62 136.04 115.50 90.53 132.41 % Of Sales - 13.74% 15.46% 17.63% 20.05% 18.47% 15.44% 13.94% 9.38% 6.38% 10.85% General & Admin Exp. - 89.97 93.26 88.02 82.51 94.82 196.55 200.15 566.05 722.03 145.52 % Of Sales - 5.18% 6.47% 8.21% 8.75% 8.44% 21.73% 20.51% 45.97% 50.90% 11.92% Selling & Distn. Exp. - 73.92 93.79 56.88 53.45 61.44 66.88 87.17 52.96 65.40 132.40 % Of Sales - 4.26% 6.50% 5.30% 5.67% 5.47% 7.39% 8.93% 4.30% 4.61% 10.85% Miscellaneous Exp. - 0.00 0.00 3.70 8.95 3.28 3.48 19.29 10.15 28.13 132.40 % Of Sales - 0% 0% 0.35% 0.95% 0.29% 0.38% 1.98% 0.82% 1.98% 2.08% EBITDA 239.43 253.88 50.91 -92.92 -43.55 95.46 -90.61 -58.32 17.35 165.81 142.28 EBITDA Margin 13.84% 14.63% 3.53% -8.66% -4.62% 8.49% -10.02% -5.98% 1.41% 11.69% 11.66% Other Income 36.31 40.83 30.39 41.85 42.07 47.37 99.17 101.54 3,280.20 7.19 22.71 Interest 8.17 7.62 10.42 9.38 2.07 1.30 1.28 0.62 3.17 2.00 2.29 Depreciation 112.24 108.41 105.45 105.98 83.19 75.89 71.09 61.71 45.04 39.41 34.99 PBT 159.33 178.68 -34.57 -166.43 -86.75 65.65 -63.81 -19.11 3,249.34 131.60 127.70 Tax 19.70 19.72 0.00 20.61 -31.32 11.56 -7.50 -27.91 692.74 27.73 23.69 Tax Rate 12.36% 10.79% 0.00% -7.38% 36.10% 17.61% 11.75% 146.05% 21.32% 21.07% 19.08% PAT 139.63 162.96 -92.18 -299.70 -55.43 54.08 -56.32 8.80 2,556.60 103.87 100.48 PAT before Minority Interest 139.63 162.96 -92.18 -299.70 -55.43 54.08 -56.32 8.80 2,556.60 103.87 100.48 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.07% 9.39% -6.39% -27.95% -5.88% 4.81% -6.23% 0.90% 207.62% 7.32% 8.23% PAT Growth 353.87% - - - - - - -99.66% 2,361.35% 3.37% EPS 19.83 23.15 -13.09 -42.57 -7.87 7.68 -8.00 1.25 363.15 14.75 14.27

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,109.03 2,110.97 1,785.11 1,343.02 1,269.83 1,235.14 1,103.71 1,188.19 1,379.90 1,540.06 1,332.65 Net Sales Growth 15.61% 18.25% 32.92% 5.76% 2.81% 11.91% -7.11% -13.89% -10.40% 15.56% Cost Of Goods Sold 875.62 751.11 637.70 482.45 356.91 302.14 308.63 364.19 274.97 188.77 386.97 Gross Profit 1,233.41 1,359.86 1,147.41 860.57 912.92 933.00 795.08 823.99 1,104.93 1,351.28 945.67 GP Margin 58.48% 64.42% 64.28% 64.08% 71.89% 75.54% 72.04% 69.35% 80.07% 87.74% 70.96% Total Expenditure 1,859.79 1,846.11 1,698.23 1,388.58 1,197.04 1,144.03 1,154.53 1,269.21 1,358.21 1,357.62 1,168.77 Power & Fuel Cost - 108.16 107.14 102.84 78.05 68.89 73.02 76.39 49.23 41.62 38.25 % Of Sales - 5.12% 6.00% 7.66% 6.15% 5.58% 6.62% 6.43% 3.57% 2.70% 2.87% Employee Cost - 402.21 403.20 356.41 330.49 306.97 273.28 238.52 200.64 169.04 255.92 % Of Sales - 19.05% 22.59% 26.54% 26.03% 24.85% 24.76% 20.07% 14.54% 10.98% 19.20% Manufacturing Exp. - 242.87 227.83 194.60 193.21 215.73 232.08 147.23 125.30 103.70 150.54 % Of Sales - 11.51% 12.76% 14.49% 15.22% 17.47% 21.03% 12.39% 9.08% 6.73% 11.30% General & Admin Exp. - 139.75 138.44 119.02 109.60 123.98 147.90 229.37 594.53 744.66 167.66 % Of Sales - 6.62% 7.76% 8.86% 8.63% 10.04% 13.40% 19.30% 43.09% 48.35% 12.58% Selling & Distn. Exp. - 202.01 183.92 129.56 120.68 122.52 116.12 197.24 108.38 107.77 166.84 % Of Sales - 9.57% 10.30% 9.65% 9.50% 9.92% 10.52% 16.60% 7.85% 7.00% 12.52% Miscellaneous Exp. - 0.00 0.00 3.70 8.11 3.81 3.50 16.26 5.16 2.06 166.84 % Of Sales - 0% 0% 0.28% 0.64% 0.31% 0.32% 1.37% 0.37% 0.13% 0.19% EBITDA 249.24 264.86 86.88 -45.56 72.79 91.11 -50.82 -81.02 21.69 182.44 163.88 EBITDA Margin 11.82% 12.55% 4.87% -3.39% 5.73% 7.38% -4.60% -6.82% 1.57% 11.85% 12.30% Other Income 38.48 35.32 31.59 38.52 47.51 50.19 91.31 98.41 3,278.19 5.50 19.11 Interest 23.54 21.03 22.66 17.31 6.11 5.12 7.85 7.52 8.01 3.36 2.90 Depreciation 120.56 124.56 123.16 113.44 91.17 84.36 81.67 67.37 50.51 43.52 38.79 PBT 143.62 154.59 -27.35 -137.80 23.03 51.82 -49.02 -57.50 3,241.36 141.07 141.31 Tax 12.78 17.07 8.80 25.86 -11.09 17.15 11.97 -33.64 696.23 32.58 29.30 Tax Rate 8.90% 11.04% -10.36% -14.66% -48.15% 33.10% -24.42% 58.50% 21.48% 23.09% 21.27% PAT 130.84 137.52 -93.76 -202.23 33.06 34.67 -61.00 -23.87 2,545.13 108.49 108.48 PAT before Minority Interest 130.84 137.52 -93.76 -202.23 33.06 34.67 -61.00 -23.87 2,545.13 108.49 108.48 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.20% 6.51% -5.25% -15.06% 2.60% 2.81% -5.53% -2.01% 184.44% 7.04% 8.14% PAT Growth 252.25% - - - -4.64% - - - 2,245.96% 0.01% EPS 18.59 19.53 -13.32 -28.73 4.70 4.92 -8.66 -3.39 361.52 15.41 15.41

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,459.75 2,294.63 2,384.27 2,672.04 2,697.33 2,647.18 2,731.93 2,761.67 1,130.73 1,027.15 Share Capital 14.08 14.08 14.08 14.08 14.08 14.08 14.08 14.07 18.18 18.17 Total Reserves 2,440.55 2,277.49 2,358.14 2,647.28 2,675.50 2,628.28 2,714.02 2,747.01 1,111.11 1,007.83 Non-Current Liabilities 129.93 81.13 113.21 139.63 50.27 29.68 26.79 50.07 70.40 63.66 Secured Loans 60.81 38.22 63.65 89.01 0.00 0.00 0.00 0.33 0.44 0.46 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 37.86 35.80 41.91 39.96 30.41 23.51 14.60 10.76 25.33 12.58 Current Liabilities 519.53 465.75 388.66 310.42 371.45 348.27 271.50 295.88 301.81 282.61 Trade Payables 261.65 249.49 244.47 157.08 188.57 208.22 192.69 211.51 228.28 189.63 Other Current Liabilities 98.87 80.41 119.82 125.82 168.06 115.02 67.56 60.40 56.73 47.43 Short Term Borrowings 21.37 0.00 12.36 11.43 0.00 15.21 0.00 0.00 0.55 7.90 Short Term Provisions 137.64 135.85 12.01 16.09 14.83 9.81 11.25 23.97 16.25 37.65 Total Liabilities 3,109.21 2,841.51 2,886.14 3,122.09 3,119.05 3,025.13 3,030.22 3,107.62 1,502.94 1,373.42 Net Block 1,274.69 1,164.94 1,235.94 963.12 846.23 824.94 785.16 551.12 464.17 381.20 Gross Block 1,925.53 1,718.29 1,690.90 1,323.61 1,128.33 1,037.52 939.38 655.08 535.64 414.65 Accumulated Depreciation 650.84 553.35 454.95 360.49 282.11 212.58 154.22 103.96 71.47 33.45 Non Current Assets 1,533.35 1,454.22 1,589.96 1,748.12 1,813.69 1,520.42 1,177.12 895.56 815.69 744.42 Capital Work in Progress 31.03 122.36 147.82 494.18 567.73 330.84 90.25 235.53 247.26 232.65 Non Current Investment 45.62 42.74 38.98 126.22 287.52 252.77 245.36 86.97 85.16 102.52 Long Term Loans & Adv. 182.01 124.18 167.22 164.61 112.21 111.88 56.36 21.94 19.11 28.05 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,566.34 1,383.94 1,292.76 1,370.49 1,305.37 1,504.71 1,853.10 2,212.05 687.25 629.00 Current Investments 0.00 1.34 1.54 263.58 236.43 419.10 800.75 895.55 8.00 8.04 Inventories 584.06 500.53 480.19 460.69 386.12 315.57 274.18 207.76 253.98 200.66 Sundry Debtors 748.14 558.41 472.08 380.84 360.48 323.10 331.35 231.74 296.49 264.73 Cash & Bank 88.63 129.06 157.28 99.03 57.59 205.37 191.03 673.61 10.16 10.94 Other Current Assets 145.51 23.93 25.93 29.99 264.75 241.57 255.79 203.40 118.61 144.63 Short Term Loans & Adv. 109.53 170.67 155.75 136.35 207.13 182.77 192.16 145.51 100.40 121.55 Net Current Assets 1,046.81 918.19 904.10 1,060.07 933.91 1,156.45 1,581.60 1,916.17 385.44 346.38 Total Assets 3,099.69 2,838.16 2,882.72 3,118.61 3,119.06 3,025.13 3,030.22 3,107.61 1,502.94 1,373.42

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,450.59 2,438.30 2,435.30 2,618.41 2,556.83 2,531.35 2,619.91 2,680.08 1,063.62 954.33 Share Capital 14.08 14.08 14.08 14.08 14.08 14.08 14.08 14.07 18.18 18.17 Total Reserves 2,431.39 2,421.16 2,409.18 2,593.65 2,535.00 2,512.44 2,601.99 2,665.42 1,044.00 935.01 Non-Current Liabilities 98.72 92.27 108.03 143.88 49.16 43.72 10.10 46.46 64.49 76.02 Secured Loans 60.81 38.22 63.65 89.01 0.00 0.00 0.00 0.33 0.44 22.98 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 37.86 35.80 41.91 39.96 30.41 23.51 14.60 10.76 25.33 12.58 Current Liabilities 991.97 737.60 639.60 552.13 505.76 566.73 502.92 463.51 392.62 275.09 Trade Payables 402.55 351.26 290.69 183.19 210.08 250.22 221.41 226.23 210.73 163.95 Other Current Liabilities 107.15 93.01 128.34 135.06 176.97 122.04 68.45 63.03 68.01 60.56 Short Term Borrowings 340.29 155.27 208.08 215.69 100.63 184.03 199.67 150.29 97.62 12.93 Short Term Provisions 141.98 138.06 12.50 18.19 18.09 10.44 13.39 23.97 16.25 37.65 Total Liabilities 3,541.28 3,268.17 3,182.93 3,314.42 3,111.75 3,141.80 3,132.93 3,190.05 1,520.73 1,305.44 Net Block 1,299.57 1,252.40 1,256.66 990.03 880.42 866.06 806.29 574.45 487.22 402.60 Gross Block 1,993.53 1,919.54 1,750.29 1,379.74 1,193.56 1,098.27 975.96 689.74 561.37 439.53 Accumulated Depreciation 693.96 667.14 493.63 389.70 313.14 232.21 169.67 115.29 74.15 36.92 Non Current Assets 1,505.67 1,521.50 1,591.06 1,666.02 1,734.44 1,455.33 1,093.64 853.59 772.27 673.34 Capital Work in Progress 30.67 122.71 147.45 493.81 567.50 330.47 92.39 238.15 249.98 237.13 Non Current Investment 0.02 0.02 0.16 0.28 159.12 134.38 129.20 9.20 9.51 5.54 Long Term Loans & Adv. 150.61 124.92 168.07 165.59 112.89 112.90 56.37 24.05 25.57 28.05 Other Non Current Assets 24.80 21.45 18.72 16.30 14.52 11.52 9.39 7.74 0.00 0.00 Current Assets 2,029.47 1,743.32 1,588.47 1,644.92 1,377.32 1,686.47 2,039.29 2,336.47 748.46 632.11 Current Investments 0.00 1.34 1.54 263.58 236.43 419.10 800.75 895.55 8.00 8.04 Inventories 988.74 736.26 625.23 600.22 538.34 396.54 338.66 272.86 281.71 230.57 Sundry Debtors 778.81 642.31 588.62 495.43 250.27 390.14 436.05 276.92 315.32 220.09 Cash & Bank 117.63 158.16 185.36 114.10 82.45 233.81 200.99 681.46 16.14 20.13 Other Current Assets 144.29 29.79 31.31 34.60 269.83 246.88 262.83 209.68 127.29 153.28 Short Term Loans & Adv. 101.58 175.46 156.40 136.99 207.62 183.04 194.18 145.51 98.80 122.77 Net Current Assets 1,037.50 1,005.72 948.86 1,092.80 871.56 1,119.74 1,536.37 1,872.95 355.84 357.02 Total Assets 3,535.14 3,264.82 3,179.53 3,310.94 3,111.76 3,141.80 3,132.93 3,190.06 1,520.73 1,305.45

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 72.29 -41.57 -117.33 -158.31 -32.61 -41.84 -251.30 -66.25 140.78 116.58 PBT 182.68 -92.18 -279.09 -86.75 65.65 -63.81 -19.11 3,249.34 131.60 124.17 Adjustment 107.30 165.38 203.30 72.20 49.68 -6.17 -7.08 -3,214.36 72.37 56.10 Changes in Working Capital -217.41 -114.62 -41.45 -147.82 -147.63 25.49 -217.91 -103.24 -35.89 -32.73 Cash after chg. in Working capital 72.57 -41.42 -117.24 -162.37 -32.30 -44.49 -244.10 -68.27 168.08 147.55 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.28 -0.15 -0.09 4.06 -0.31 2.65 -7.20 2.01 -27.30 -30.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -132.07 53.24 202.50 106.31 -80.39 -35.59 -322.63 1,648.30 -131.91 -86.73 Net Fixed Assets -115.91 -1.93 -20.93 -121.73 -327.70 -338.73 -139.02 -107.71 -135.60 154.89 Net Investments -1.54 -3.56 349.28 134.15 147.92 374.24 -63.59 -889.36 17.40 42.09 Others -14.62 58.73 -125.85 93.89 99.39 -71.10 -120.02 2,645.37 -13.71 -283.71 Cash from Financing Activity -4.61 -48.06 -61.76 95.80 -45.07 -21.02 -44.89 -929.51 -8.95 -38.63 Net Cash Inflow / Outflow -64.39 -36.39 23.41 43.81 -158.07 -98.45 -618.82 652.53 -0.08 -8.77 Opening Cash & Equivalents 125.65 155.67 94.13 52.60 203.08 188.66 660.31 7.77 7.86 19.71 Closing Cash & Equivalent 60.58 125.65 155.67 94.13 52.60 203.08 188.66 660.31 7.77 10.94

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -7.02 14.00 -85.09 -259.61 32.98 19.82 -327.77 -112.34 68.19 111.91 PBT 154.59 -84.96 -176.36 21.97 51.48 -48.21 -57.44 3,241.14 141.25 137.68 Adjustment 148.70 197.32 132.84 80.46 65.65 18.79 6.80 -3,207.66 53.31 39.65 Changes in Working Capital -293.89 -91.99 -29.36 -354.43 -69.78 53.58 -264.94 -146.67 -98.65 -34.16 Cash after chg. in Working capital 9.40 20.37 -72.88 -252.00 47.35 24.15 -315.57 -113.20 95.91 143.16 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.42 -6.37 -12.21 -7.62 -14.36 -4.34 -12.20 0.86 -27.72 -31.25 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -241.23 50.40 202.81 102.40 -73.56 -35.91 -286.01 1,648.33 -127.87 -85.33 Net Fixed Assets -115.91 -1.93 -20.93 -121.73 -327.70 -338.73 -139.02 -107.71 -135.60 154.89 Net Investments -1.54 -3.56 349.28 134.15 147.92 374.24 -63.59 -889.36 17.40 42.09 Others -123.78 55.89 -125.54 89.98 106.22 -71.42 -83.40 2,645.40 -9.67 -282.31 Cash from Financing Activity 183.76 -106.31 -81.30 191.23 -121.07 -62.30 -2.42 -881.13 59.23 -33.42 Net Cash Inflow / Outflow -64.49 -41.91 36.42 34.01 -161.65 -78.40 -616.19 654.86 -0.46 -6.84 Opening Cash & Equivalents 154.75 183.75 109.20 77.46 231.52 197.05 666.07 11.21 11.67 26.96 Closing Cash & Equivalent 89.58 154.75 183.75 109.20 77.46 231.52 197.05 666.07 11.21 20.13

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 348.67 325.51 336.94 378.00 382.01 375.30 387.60 392.55 124.27 112.94 ROA 5.48% -3.22% -9.98% -1.78% 1.76% -1.86% 0.29% 110.90% 7.22% 7.74% ROE 6.87% -3.95% -11.91% -2.07% 2.03% -2.10% 0.32% 131.43% 9.64% 10.19% ROCE 7.72% -3.38% -10.21% -3.08% 2.50% -2.32% -0.67% 167.06% 12.33% 12.75% Fixed Asset Turnover 0.95 0.85 0.71 0.77 1.04 0.92 1.22 2.07 2.99 2.25 Receivable days 137.38 130.40 145.14 143.48 110.99 132.06 105.30 78.26 72.16 69.53 Inventory Days 114.04 124.11 160.11 163.90 113.93 119.00 90.13 68.41 58.46 57.16 Payable days 136.11 152.16 160.92 194.36 201.52 82.50 82.64 118.77 140.05 63.62 Cash Conversion Cycle 115.30 102.35 144.34 113.02 23.40 168.55 112.80 27.91 -9.43 63.06 Total Debt/Equity 0.05 0.03 0.04 0.05 0.00 0.01 0.00 0.00 0.00 0.01 Interest Cover 24.97 -7.85 -28.75 -40.82 51.47 -48.78 -29.97 1027.03 66.88 55.19

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 347.37 345.91 344.18 370.38 362.05 358.85 371.69 380.95 116.88 104.93 ROA 4.04% -2.91% -6.22% 1.03% 1.11% -1.94% -0.75% 108.06% 7.68% 8.82% ROE 5.64% -3.86% -8.04% 1.28% 1.37% -2.37% -0.90% 136.04% 10.77% 11.92% ROCE 6.34% -2.31% -5.60% 1.00% 2.12% -1.49% -1.77% 162.77% 13.42% 14.97% Fixed Asset Turnover 1.08 0.97 0.86 0.99 1.08 1.06 1.43 2.21 3.08 2.32 Receivable days 122.86 125.84 147.31 107.17 94.63 136.61 109.51 78.30 63.41 55.72 Inventory Days 149.13 139.19 166.52 163.63 138.14 121.57 93.93 73.33 60.67 59.32 Payable days 183.16 183.72 179.25 201.09 278.03 76.39 73.41 94.97 104.25 52.00 Cash Conversion Cycle 88.84 81.32 134.58 69.71 -45.27 181.78 130.03 56.65 19.82 63.05 Total Debt/Equity 0.18 0.09 0.12 0.13 0.04 0.07 0.08 0.06 0.09 0.04 Interest Cover 8.35 -2.75 -9.19 4.60 11.12 -5.25 -6.64 405.79 43.00 48.57

Top Investors:

hdfc small cap fund

dsp healthcare fund

investor education and protection fund authority ministry of corporate affairs

Annual Reports:

News Update:

Unichem Lab - Quarterly Results
4th Aug 2025, 13:58 PM

Read More
USFDA conducts inspection at Unichem Laboratories’ Roha API facility
23rd Jun 2025, 09:50 AM

The inspection closed with three observations which were more of procedural changes with none of these related to data integrity
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback